Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
Photonics Media
ABOUT US
BOOKSTORE
SUBSCRIBE
ADVERTISE

Computed Tomography Imager

MILabsRequest Info
 
Facebook Twitter LinkedIn Email
UTRECHT, Netherlands, Oct. 19, 2016 — MILabs BV has launched EXIRAD-3D, its new µm-resolution imaging technology.

The single photon emissions computed tomography (SPECT) technology is dedicated to imaging ex-vivo tissue samples. The device enables highly detailed quantitative and automated 3D scanning of radio-labeled molecules in biological tissue samples such as complete organs of small animals, and can be readily combined with x-ray computed tomography.

By cryo-cooling the tissue samples with a µm-resolution SPECT option, researchers can eliminate many tedious, time-consuming and error-prone steps from traditional quantitative 3D autoradiography.

Visit company website
About this supplier

explore related content
Photonics.com
Oct 2016
REQUEST INFO ABOUT THIS PRODUCT

* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address:
Address 2:
City:
State/Province:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required

When you click "Send Request", we will record and send your personal contact information to MILabs by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.
Photonics Marketplace
Browse Cameras & Imaging, Lasers, Optical Components, Test & Measurement, and more.
ProductsEXIRAD-3DMILabscomputed tomography imagerEurope

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2023 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.